Skip to main content
. 2016 Dec 7;22(45):9944–9953. doi: 10.3748/wjg.v22.i45.9944

Figure 6.

Figure 6

Different therapeutic options in patients with morphological poorly differentiated neuroendocrine carcinomas of the pancreas. 18FDG-PET: 18F-fluorodeoxyglucose positron emission tomography.